Table 2. Factors associated with CAP ≥ 238 dB/m vs. CAP <238 dB/m (logistic regression).
| Variables | Hemodialysis | Control | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate | Multivariate | Univariate | Multivariate | |||||
| OR (95% CI) | P | OR | P | OR (95% CI) | P | OR | P | |
| Age | 1.01 (0.99–1.02) | 0.530 | - | 1.00 (0.98–1.03) | 0.950 | - | ||
| Male | 0.92 (0.60–1.42) | 0.720 | - | 1.04 (0.58–1.86) | 0.888 | - | ||
| BMI (kg/m2) | 1.37 (1.26–1.49) | <0.001 | 1.28 (1.16–1.40) | <0.001 | 1.36 (1.22–1.52) | <0.001 | 1.30 (1.12–1.51) | 0.001 |
| DM | 2.07 (1.30–3.30) | 0.002 | 1.51 (0.81–2.82) | 0.190 | 2.28 (1.19–4.38) | 0.013 | 2.18 (0.82–5.79) | 0.119 |
| AST (IU/L) | 0.99 (0.96–1.01) | 0.260 | - | 1.02 (0.99–1.04) | 0.151 | - | ||
| ALT(IU/L) | 0.99 (0.98–1.01) | 0.710 | - | 1.02 (1.00–1.04) | 0.028 | 1.03 (1.002–1.05) | 0.032 | |
| Fasting sugar (mg/dL) | 1.01 (1.00–1.01) | 0.001 | 0.99 (0.99–1.01) | 0.940 | 1.01 (0.99–1.03) | 0.264 | - | |
| HDL, male< 40, female < 50(mg/dL) | 4.20 (2.65–6.63) | <0.001 | 2.15 (1.26–3.65) | 0.005 | 2.52 (0.84–7.52) | 0.098 | - | |
| LDL(mg/dL) | 1.00 (0.99–1.01) | 0.480 | - | 1.00 (0.99–1.01) | 0.911 | - | ||
| Total cholesterol(mg/dL) | 1.01 (0.99–1.01) | 0.090 | - | 1.00 (0.99–1.01) | 0.816 | - | ||
| Triglyceride >150(mg/dL) | 5.88 (3.60–9.60) | <0.001 | 3.28 (1.88–5.73) | <0.001 | 4.48 (1.52–13.18) | 0.006 | 5.22 (0.64–42.7) | 0.124 |
| Platelet(1000/μL) | 0.73 (0.45–1.18) | 0.200 | - | 0.52 (0.19–1.45) | 0.212 | - | ||
| LSM (kPa) | 1.00 (0.95–1.06) | 0.890 | - | 1.01 (0.98–1.04) | 0.671 | - | ||
BMI, body mass index; DM, diabetes mellitus; ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDL, High-density lipoprotein; CAP, Controlled Attenuation Parameter; LSM, liver stiffness measurement; LDL, low-density lipoprotein